# Comprehensive Filtering Effectiveness Analysis

Generated: 2025-09-22 11:21:07

---

## Executive Summary

- **Total Users Analyzed**: 6
- **Average Removal Rate**: 2.1%
- **Average Outlier Rate**: 2.1%
- **Average CI Improvement**: 14.0%

## Cohort-Level Impact

### Weight Change Statistics

| Metric | Raw | Filtered | Improvement |
|--------|-----|----------|-------------|
| Mean Weight Change | 26.88% | -0.81% | -27.69% |

### Clinical Success Rates

| Threshold | Raw | Filtered | Delta |
|-----------|-----|----------|-------|
| 5% Weight Loss | 0.0% | 0.0% | +0.0% |
| 10% Weight Loss | 0.0% | 0.0% | +0.0% |

### User Inclusion Impact

| Stage | Raw | Filtered | Change |
|-------|-----|----------|--------|
| Valid Baseline | 2 | 1 | -1 |
| Valid Endpoint | 2 | 1 | -1 |

### Statistical Power Improvements

- **Variance Reduction**: 100.0%
- **Effect Size Improvement**: 0.041

## Individual User Analysis

Analyzed 6 users in detail.

| User ID | Measurements | Filtered | Removal Rate | Outlier Rate |
|---------|--------------|----------|--------------|-------------|
| 001adb56 | 85 | 79 | 7.1% | 7.1% |
| 002fe680 | 34 | 33 | 2.9% | 2.9% |
| 003c63c3 | 20 | 20 | 0.0% | 0.0% |
| 0069687c | 63 | 62 | 1.6% | 1.6% |
| 00775c99 | 213 | 212 | 0.5% | 0.5% |
| 00879ed6 | 347 | 345 | 0.6% | 0.6% |

## Key Findings

### Data Quality Improvements

1. **Outlier Detection**: Successfully identified and removed 11 outliers across all users
2. **Temporal Consistency**: Reduced daily weight volatility by an average of 0.44kg
3. **Impossible Changes**: Eliminated 5 physiologically impossible weight changes

### Clinical Impact

1. **Direction Errors**: Prevented 0 cases where weight change direction would be misclassified
2. **Confidence Intervals**: Improved measurement confidence by 14.0% on average

## Generated Visualizations

The following visualization files have been generated:

- `reports/visualizations/user_001adb56-40a5-4ef2-a092-e20915e0fb81/time_series_001adb56.png` - time_series_001adb56.png
- `reports/visualizations/user_001adb56-40a5-4ef2-a092-e20915e0fb81/residual_plot_001adb56.png` - residual_plot_001adb56.png
- `reports/visualizations/user_001adb56-40a5-4ef2-a092-e20915e0fb81/daily_changes_001adb56.png` - daily_changes_001adb56.png
- `reports/visualizations/user_001adb56-40a5-4ef2-a092-e20915e0fb81/dashboard_001adb56.png` - dashboard_001adb56.png
- `reports/visualizations/user_002fe680-cd89-4599-9ab3-e1408bdb9975/time_series_002fe680.png` - time_series_002fe680.png
- `reports/visualizations/user_002fe680-cd89-4599-9ab3-e1408bdb9975/residual_plot_002fe680.png` - residual_plot_002fe680.png
- `reports/visualizations/user_002fe680-cd89-4599-9ab3-e1408bdb9975/daily_changes_002fe680.png` - daily_changes_002fe680.png
- `reports/visualizations/user_002fe680-cd89-4599-9ab3-e1408bdb9975/dashboard_002fe680.png` - dashboard_002fe680.png
- `reports/visualizations/user_003c63c3-3646-497d-87f0-fcb9754cb327/time_series_003c63c3.png` - time_series_003c63c3.png
- `reports/visualizations/user_003c63c3-3646-497d-87f0-fcb9754cb327/residual_plot_003c63c3.png` - residual_plot_003c63c3.png
- `reports/visualizations/user_003c63c3-3646-497d-87f0-fcb9754cb327/daily_changes_003c63c3.png` - daily_changes_003c63c3.png
- `reports/visualizations/user_003c63c3-3646-497d-87f0-fcb9754cb327/dashboard_003c63c3.png` - dashboard_003c63c3.png
- `reports/visualizations/user_0069687c-c1b2-420e-bfae-009a284d13fe/time_series_0069687c.png` - time_series_0069687c.png
- `reports/visualizations/user_0069687c-c1b2-420e-bfae-009a284d13fe/residual_plot_0069687c.png` - residual_plot_0069687c.png
- `reports/visualizations/user_0069687c-c1b2-420e-bfae-009a284d13fe/daily_changes_0069687c.png` - daily_changes_0069687c.png
- `reports/visualizations/user_0069687c-c1b2-420e-bfae-009a284d13fe/dashboard_0069687c.png` - dashboard_0069687c.png
- `reports/visualizations/user_00775c99-feba-4683-af8b-21c493841508/time_series_00775c99.png` - time_series_00775c99.png
- `reports/visualizations/user_00775c99-feba-4683-af8b-21c493841508/residual_plot_00775c99.png` - residual_plot_00775c99.png
- `reports/visualizations/user_00775c99-feba-4683-af8b-21c493841508/daily_changes_00775c99.png` - daily_changes_00775c99.png
- `reports/visualizations/user_00775c99-feba-4683-af8b-21c493841508/dashboard_00775c99.png` - dashboard_00775c99.png
- `reports/visualizations/cohort_distribution_overlay.png` - cohort_distribution_overlay.png
- `reports/visualizations/outlier_clustering_map.png` - outlier_clustering_map.png
- `reports/visualizations/trajectory_fans.png` - trajectory_fans.png

## Recommendations

Based on the analysis results, we recommend:

1. **Continue Filtering**: The filtering process significantly improves data quality without compromising clinical validity
2. **Source Monitoring**: Pay special attention to data sources with high outlier rates
3. **Threshold Tuning**: Consider adjusting quality thresholds based on source reliability
4. **Regular Validation**: Implement periodic manual review of filtered data

## Technical Details

### Configuration Used

```toml
quality_threshold = 0.46
initial_variance = 0.364
```

### Analysis Parameters

- Analysis timestamp: 2025-09-22T11:21:02.715236
- Cohort size: 6 users
- Minimum measurements per user: 20

---

*End of Report*
